Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,646 shares at $151.33 ($704K) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Scheduled sale ($704k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.57 | 110 | $16K | 2.3% |
| 2 | $150.70 | 1,000 | $151K | 21.4% |
| 3 | $151.33 | 1,106 | $167K | 23.8% |
| 4 | $151.33 | 1,106 | $167K | 23.8% |
| 5 | $152.53 | 582 | $89K | 12.6% |
| 6 | $152.53 | 582 |
| $89K |
| 12.6% |
| 7 | $153.48 | 160 | $25K | 3.5% |
| Total | $151.53 avg | 4,646 | $704K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |